Literature DB >> 3133306

Infection with live mycobacteria inhibits in vitro detection of Ia antigen on macrophages.

R N Mshana1, R C Hastings, J L Krahenbuhl.   

Abstract

Both antigen-specific and non-specific anergy are common features of disseminated mycobacterial infections, and the pathogenesis of such anergy is as yet not fully understood. To date, most studies have focused on the efferent limb of the immune response, and no detailed information is available on the early macrophage-T cell interaction and its consequence on T cell clonal proliferation. To gain information on this crucial phase of mycobacteriosis, we have conducted studies to evaluate the effect of M. kansasii infection on Ia expression induced by T cell-derived lymphokine and have assessed whether such cells can adequately present either mycobacterial or allogeneic antigens to T cells. In vitro infection of mouse resident peritoneal macrophages with live but not heat-killed M. kansasii resulted in a significantly reduced percentage of cells expressing monoclonal antibody detectable Ia antigen following optimal stimulation with crude lymphokine preparations or recombinant mouse gamma interferon. In parallel experiments, macrophages infected with the mycobacteria were co-cultured with syngeneic in vivo M. kansasii sensitized non-adherent, nylon-wool purified lymph node cells, and lymphoproliferation was measured by [3H]thymidine incorporation. It was shown that in co-cultures with macrophages infected with live M. kansasii, the lymphocyte proliferation was marked even in very low infection ratios. In contrast, the response to heat-killed bacilli was dose dependent, reaching peak levels only in high infection ratios. The ability of infected macrophages to present allogeneic antigens was assessed using the mixed leukocyte reaction. Macrophages infected with heat-killed M. kansasii were able to induce a mixed leukocyte reaction similar to uninfected macrophages whereas macrophages infected with live M. kansasii were unable to stimulate allogeneic T cells. These findings may have implications on immunological disturbances often seen in mycobacterial infections, such as leprosy, in which there can be large numbers of non-toxic viable intracellular bacilli.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3133306     DOI: 10.1016/S0171-2985(88)80090-1

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  9 in total

1.  Multiple mechanisms allow Mycobacterium tuberculosis to continuously inhibit MHC class II-mediated antigen presentation by macrophages.

Authors:  Stewart T Chang; Jennifer J Linderman; Denise E Kirschner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

2.  Mycobacterium avium-Mycobacterium intracellular complex-induced suppression of T-cell proliferation in vitro by regulation of monocyte accessory cell activity.

Authors:  I Tsuyuguchi; H Kawasumi; T Takashima; T Tsuyuguchi; S Kishimoto
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

3.  Morphological aspects of the interaction of Bacillus Calmette-Guérin with urothelial bladder cells in vivo and in vitro: relevance for antitumor activity?

Authors:  J S Teppema; E C de Boer; P A Steerenberg; A P van der Meijden
Journal:  Urol Res       Date:  1992

4.  Induction of unresponsiveness to gamma interferon in macrophages infected with Mycobacterium leprae.

Authors:  L D Sibley; J L Krahenbuhl
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

5.  Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes.

Authors:  J Gercken; J Pryjma; M Ernst; H D Flad
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  Major histocompatibility complex class II antigen expression on leucocyte subpopulations in the draining lymph node and tumour in the early phase of bacillus-Calmette-Guérin-induced tumour regression.

Authors:  P A Steerenberg; W H De Jong; E Geerse; A De Graaf; R J Scheper; W Den Otter; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

7.  Mycobacterium bovis BCG urease attenuates major histocompatibility complex class II trafficking to the macrophage cell surface.

Authors:  Khalid Sendide; Ala-Eddine Deghmane; Jean-Marc Reyrat; Amina Talal; Zakaria Hmama
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

8.  The inhibitory effects of Mycobacterium tuberculosis on MHC class II expression by monocytes activated with riminophenazines and phagocyte stimulants.

Authors:  A A Wadee; R H Kuschke; T G Dooms
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

9.  Major histocompatibility complex class II antigen expression during potentiation of line-10 tumor immunity after intralesional administration of bacillus Calmette-Guérin.

Authors:  P A Steerenberg; W H De Jong; E Geerse; B J Aleva; C M Besselink; B T Van Rens; V P Rutten; L G Poels; R J Scheper; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.